381 results on '"MROWIETZ, Ulrich"'
Search Results
2. SARS‐CoV‐2 infection among psoriasis patients in Germany: Data from the German registries PsoBest and CoronaBest
3. Perception and Impact of COVID-19 Pandemic in Psoriasis Patients: Data from the German PsoBest and the CoronaBest Registries
4. Supersäfte
5. Nouvelle Cuisine
6. Psoriasis and its impact on close relatives and partners of patients – A cross‐sectional questionnaire study
7. Orismilast in moderate-to-severe psoriasis: Efficacy and safety from a 16-week, randomized, double-blinded, placebo-controlled, dose-finding, and phase 2b trial (IASOS)
8. Psoriasis
9. Papulosquamous Disorders
10. Ixekizumab im Vergleich zu Fumarsäureestern und Methotrexat bei der Behandlung der Nagelpsoriasis bei Patienten mit mittelschwerer bis schwerer Psoriasis
11. Prioritäten
12. Bimekizumab Efficacy in Patients with Moderate to Severe Plaque Psoriasis and Hypertension, Elevated Body Mass Index, or Hyperglycemia: Results Through 3 years of Treatment in 5 Phase 3/3b Trials
13. Ixekizumab versus FAEs and methotrexate in treatment of nail psoriasis in patients with moderate‐to‐severe psoriasis
14. Mobiles Lächeln
15. Papulosquamous Disorders
16. Baustellen
17. Implementing wellbeing in the management of psoriasis: An expert recommendation
18. Verlesungen
19. Charakterisierung von Patienten mit Psoriasisarthritis in der dermatologischen und rheumatologischen Versorgung: Analyse von zwei Registern
20. B-Werbung
21. Psoriasis
22. Characterization of patients with psoriatic arthritis in dermatologic and rheumatologic care: analysis of two registries
23. Straßenradfahrer
24. Patient-reported well-being in value-based care using tildrakizumab in a real-world setting: 28-week interim data of the phase IV POSITIVE study
25. Klimahaut
26. Gasprom
27. Kerferische Kost
28. Forderalismus
29. Rapid and sustained improvements in Generalized Pustular Psoriasis Physician Global Assessment scores with spesolimab for treatment of generalized pustular psoriasis flares in the randomized, placebo-controlled Effisayil 1 study
30. Erythematöse, papulonodöse und erythematosquamöse Erkrankungen
31. Psoriasis
32. Förderalismus
33. Skin Colonization with S. aureus Can Lead to Increased NLRP1 Inflammasome Activation in Patients with Atopic Dermatitis
34. Patient-reported well-being in value-based care using tildrakizumab in a real-world setting: protocol of a multinational, phase IV, 1-cohort prospective observational study (the POSITIVE study)
35. Komorbiditäten der Psoriasis
36. Der Filler
37. Erythematöse, papulonodöse und erythematosquamöse Erkrankungen
38. Using the upgrade criteria of the European Psoriasis Consensus is best practice care according to the people-centred healthcare concept of the World Health Organization
39. Osen
40. Bimekizumab maintenance of response through three years in patients with moderate to severe plaque psoriasis who responded at Week 16: Results from the BE BRIGHT open-label extension trial
41. Efficacy and safety of apremilast in patients with limited skin involvement, plaque psoriasis in special areas and impaired quality of life: Results from the EMBRACE randomized trial
42. Tempo-Limit
43. Faculty Opinions recommendation of Time to relapse after discontinuing systemic treatment for psoriasis: A systematic review.
44. Russisch duschen
45. Measuring patient-relevant benefits in the treatment of psoriasis with the Patient Benefit Index: development and preliminary validation of a 10-item short form
46. ESDR319 - S. aureus can induce NLRP1 inflammasome activation in patients with atopic dermatitis
47. 33130 Effect of tildrakizumab on work/study-related productivity: Pooled analysis from reSURFACE 1 and reSURFACE 2 phase 3 trials
48. Oral Dimethyl Fumarate Targets HCA2-Expressing Skin Cells in the Imiquimod Mouse Model
49. 32924 Sustained treatment effect of spesolimab over 12 weeks for generalized pustular psoriasis flares; results from the Effisayil 1 study
50. Dress-Code
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.